NEW YORK, May 21 – Agilent Technologies said Monday it had reached an agreement with Harvard University to jointly develop nanopore technology for the analysis of nucleic acids.

The terms of the multiyear deal were not disclosed, but Agilent did say the project could be extended.

The company said it would work with Harvard to develop technology that converts nucleotide sequences into electronic signatures, helping to speed up the sequencing process. Agilent did not say when it expected to release nanopore technology to market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.